Skip to content

In the BioHarmony Drug Report Database

Velaglucerase alfa

Vpriv (velaglucerase alfa) is an enzyme pharmaceutical. Velaglucerase alfa was first approved as Vpriv on 2010-02-26. It is used to treat gaucher disease in the USA. It has been approved in Europe to treat gaucher disease.
Trade Name Vpriv
Common Name Velaglucerase alfa
Indication gaucher disease
Drug Class Enzymes
Velaglucerase alfa
Get full access now